- Home
- MSAI vs NRBO Comparison
MSAI vs NRBO Comparison
Compare MSAI & NRBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSAI
- NRBO
- Stock Information
- Founded
- MSAI 1995
- NRBO N/A
- Country
- MSAI United States
- NRBO United States
- Employees
- MSAI N/A
- NRBO N/A
- Industry
- MSAI
- NRBO Biotechnology: Pharmaceutical Preparations
- Sector
- MSAI
- NRBO Health Care
- Exchange
- MSAI Nasdaq
- NRBO Nasdaq
- Market Cap
- MSAI 29.7M
- NRBO 27.9M
- IPO Year
- MSAI N/A
- NRBO N/A
- Fundamental
- Price
- MSAI $1.69
- NRBO $2.46
- Analyst Decision
- MSAI Strong Buy
- NRBO Strong Buy
- Analyst Count
- MSAI 1
- NRBO 1
- Target Price
- MSAI $8.00
- NRBO $10.00
- AVG Volume (30 Days)
- MSAI 10.6K
- NRBO 34.1K
- Earning Date
- MSAI 11-12-2024
- NRBO 11-07-2024
- Dividend Yield
- MSAI N/A
- NRBO N/A
- EPS Growth
- MSAI N/A
- NRBO N/A
- EPS
- MSAI N/A
- NRBO N/A
- Revenue
- MSAI $7,616,000.00
- NRBO N/A
- Revenue This Year
- MSAI $208.07
- NRBO N/A
- Revenue Next Year
- MSAI $143.29
- NRBO N/A
- P/E Ratio
- MSAI N/A
- NRBO N/A
- Revenue Growth
- MSAI 13.03
- NRBO N/A
- 52 Week Low
- MSAI $1.51
- NRBO $2.08
- 52 Week High
- MSAI $14.00
- NRBO $6.75
- Technical
- Relative Strength Index (RSI)
- MSAI 38.51
- NRBO 39.90
- Support Level
- MSAI $1.89
- NRBO $2.37
- Resistance Level
- MSAI $2.01
- NRBO $2.99
- Average True Range (ATR)
- MSAI 0.09
- NRBO 0.30
- MACD
- MSAI -0.01
- NRBO 0.00
- Stochastic Oscillator
- MSAI 0.00
- NRBO 22.22
About MSAI Infrared Cameras Holdings Inc.
MultiSensor AI Holdings Inc develops and sells a full-stack, AI-driven predictive maintenance solution. MultiSensor AI's SmartIR and associated software platforms, powered by AWS, leverage MSAI-built thermal imaging, visible imaging, acoustic imaging, vibration, and laser sensing devices for condition-based monitoring of critical mechanical and electrical assets and manufactured outputs. Its solutions are deployed by organizations to protect critical assets across a wide range of industries including distribution & logistics, manufacturing, utilities, and oil & gas. MSAI designs and manufactures digital thermal sensing solution platforms with edge and cloud-based software. The company generates the majority of its revenue from product sales.
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.